strains of bacteria characterized by exhibiting : a 7α - dehydroxylase activity of less than 50 %, and a bile acid deconjugation activity of less than 50 %, and descendants , mutants and derivatives thereof preserving activities and ; and a pharmaceutical composition using one or more of such strains and use of same for preventing and treating diseases associated with or caused by an altered metabolism of bile acids .